Zobrazeno 1 - 2
of 2
pro vyhledávání: '"GLO I, glyoxalase I"'
Autor:
Ryoko Takasawa, Sei-ichi Tanuma, Yoko Ogino, Yusuke Takai, Risa Ichida, Minoru Morita, Takayuki Yamamoto, Sadao Mori, Hiroko Maruki-Uchida, Umehara Masahiro, Sai Masahiko, Atsushi Yoshimori, Aya Nishida, Mana Inada, Akira Sato, Nami Shimada
Publikováno v:
Biochemistry and Biophysics Reports
Biochemistry and Biophysics Reports, Vol 20, Iss, Pp-(2019)
Biochemistry and Biophysics Reports, Vol 20, Iss, Pp-(2019)
Passion fruit seed extract (PFSE), a product rich in stilbenes such as piceatannol and scirpusin B, has various physiological effects. It is unclear whether PFSE and its stilbene derivatives inhibit cancer cell proliferation via human glyoxalase I (G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dadd8a6cadac3628f35d7ef6a4e278c5
https://doi.org/10.1016/j.bbrep.2019.100684
https://doi.org/10.1016/j.bbrep.2019.100684
Autor:
Yamamoto T; Research and Development Institute, Health Science Research Center, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, 230-8504, Japan., Sato A; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan., Takai Y; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan., Yoshimori A; Institute for Theoretical Medicine Inc., 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-0012, Japan., Umehara M; Research and Development Institute, Health Science Research Center, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, 230-8504, Japan., Ogino Y; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan., Inada M; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan., Shimada N; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan., Nishida A; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan., Ichida R; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan., Takasawa R; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan., Maruki-Uchida H; Research and Development Institute, Health Science Research Center, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, 230-8504, Japan., Mori S; Research and Development Institute, Health Science Research Center, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, 230-8504, Japan., Sai M; Research and Development Institute, Health Science Research Center, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, 230-8504, Japan., Morita M; Research and Development Institute, Health Science Research Center, Morinaga and Company Limited, 2-1-1 Shimosueyoshi, Tsurumi-ku, Yokohama, 230-8504, Japan., Tanuma SI; Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.; Research Institute for Science and Technology, Organization for Research Advancement, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba, 278-8510, Japan.
Publikováno v:
Biochemistry and biophysics reports [Biochem Biophys Rep] 2019 Aug 30; Vol. 20, pp. 100684. Date of Electronic Publication: 2019 Aug 30 (Print Publication: 2019).